PureSafety and eMids renew partnership
Posted on February 15, 2010 at 7:47 amPureSafety and eMids Technologies have renewed their partnership and contract for its product development center, the companies announced Friday. In the “Extended Center Model,” a dedicated eMids team works exclusively on research and development, quality assurance and other product engineering projects for Franklin-based PureSafety.
permalink | Comment on this post
TSU looks to shape research consortium
Posted on February 2, 2010 at 8:19 amMilt Capps has the lowdown on efforts to form the Capital City Research Consortium, a group that would improve the region’s technology transfer system.
permalink | Comment on this post
Stimulus grants for Vandy cancer researcher
Posted on January 29, 2010 at 7:22 amVanderbilt University Medical Center cancer investigator H. Charles Manning has received two grants, totaling $1.6 million, from the National Cancer Institute to study imaging techniques in colorectal cancer. The grants are part of the federal government’s stimulus package funded through the American Recovery and Reinvestment Act.
“The promise of molecular imaging is to rapidly and noninvasively interrogate tissues of interest without tissue sampling, such as biopsy,” said Manning. “Molecular imaging biomarkers … may enable us to determine whether a drug is working as early as a few hours after administration as well as predict whether patients will continue to respond over time. This information could spare patients the expense and potential side effects of ineffective therapies.”
permalink | Comment on this post
Canadian OK for BioMimetic
Posted on November 4, 2009 at 7:27 amCanada’s health regulators have given BioMimetic Therapeutics the go-ahead to market its Augment Bone Graft product via an Ontario-based distributor. It’ll be for sale in time for Christmas.
permalink | Comment on this post
BioMimetic does its paperwork
Posted on June 18, 2009 at 8:03 amThe Franklin-based maker of regnerative tissues has submitted several parts of its application to bring Augment Bone Graft to market. Investors are rewarding that by pushing up its shares (Ticker: BMTI) by 7 percent in pre-market action this morning.
permalink | Comment on this post
Shake it like a Polaroid picture
Posted on May 4, 2009 at 3:51 pmLouisiana-Pacific researchers will team with engineers from Simpson Strong-Tie, a builder and a group of academic researchers to simulate the 1994 Northridge quake on a seven-story condominium tower.
“The outcome of the tests could lead to taller wood-frame buildings in active seismic zones,” said John van de Lindt, a Colorado State University civil engineering professor who serves as the principal investigator for the project.
permalink | Comment on this post
Gore signs on to embryonic stem cell alternative
Posted on April 14, 2009 at 7:31 amUSA Today reports:
Former vice president Al Gore is entering the stem cell arena with an announcement today of a $20 million biotech venture in the hot area of “induced pluripotent” stem cells.
Induced cells are attracting interest from researchers and biotech firms as an alternative to embryonic stem cells. Induced cells are made by inserting four genes into ordinary skin cells, and they offer a new path for “regenerative” medical treatments.
“I just think it’s a very important breakthrough that is filled with promise and hope,” says Gore, a partner with the venture-capital firm Kleiner Perkins Caufield and Byers, which is backing the research. “I think this is one of those good news stories that comes along every once in a while.”
permalink | Comment on this post
Incubator teams with UT foundation
Posted on February 10, 2009 at 11:07 pmDowntown’s Cumberland Emerging Technologies and the University of Tennessee Research Foundation will further explore a “promising” arthritis treatment.
“Licensing this technology is an important milestone for CET,” said A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals and CET. “Not only are we adding a promising new product candidate to our development pipeline, we are also providing researchers with the resources necessary to advance this important work. This is precisely what we envisioned when we created CET to bridge the gap between the research laboratory and the commercial marketplace.”
permalink | Comment on this post
Life sciences venture ramps up in Franklin
Posted on February 3, 2009 at 11:32 amVenture Nashville reports on Nodality, a biotech product development company preparing to launch its operations in April.
Parkinson said researchers in the Nashville lab will primarily be “taking the information we develop out of our discovery labs” in the Bay Area and will be “working to convert [what is learned] into laboratory tests that could eventually be used to inform patient care.”
Recent Comments
Idiot, anybody that would invest in this guy’s ideas...
This is for Gretchen Wilson, I am so proud of you going out on your own,...
Did SItel have any dividend payments in 2009 or 2010?
I’d say planting your flag in the ground so...
Calling a bottom after the fact is not what I call nailing the bottom!
My boyfriend and I live just a few blocks away from Omega.I...
does kroger use this “window” to decide how many illegal aliens they...
Are the pens and pad of paper on the night stand taxed?...
This is hilarious. This story comes up...
Congratulations, Anaheim…you just made a deal with the...
hmmm…how are they going to make that up when they layed off 22 people...
It is not hard to look good when you are comparing year over year to...